Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2015 (2015), Article ID 379482, 6 pages
http://dx.doi.org/10.1155/2015/379482
Review Article

Disorders of the Oral Cavity in Parkinson’s Disease and Parkinsonian Syndromes

1Department of Neurology, Movement Disorders Unit, Tel Aviv Medical Center, 6423906 Tel-Aviv, Israel
2Neurology Department, Soroka University Medical Center, 84101 Beer Sheva, Israel
3Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Received 23 September 2014; Accepted 30 December 2014

Academic Editor: Francisco Grandas

Copyright © 2015 Yair Zlotnik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Seppi, D. Weintraub, M. Coelho et al., “The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease,” Movement Disorders, vol. 26, no. 3, pp. S42–S80, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S. L. Debowes, S. L. Tolle, and A. M. Bruhn, “Parkinson's disease: considerations for dental hygienists,” International Journal of Dental Hygiene, vol. 11, no. 1, pp. 15–21, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. H. Friedlander, M. Mahler, K. M. Norman, and R. L. Ettinger, “Parkinson disease: systemic and orofacial manifestations, medical and dental management,” Journal of the American Dental Association, vol. 140, no. 6, pp. 658–669, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Hanaoka and K. Kashihara, “Increased frequencies of caries, periodontal disease and tooth loss in patients with Parkinson's disease,” Journal of Clinical Neuroscience, vol. 16, no. 10, pp. 1279–1282, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. Y. Nakayama, M. Washio, and M. Mori, “Oral health conditions in patients with Parkinson's disease,” Journal of Epidemiology, vol. 14, no. 5, pp. 143–150, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Müller, R. Palluch, and J. J. Ackowski, “Caries and periodontal disease in patients with Parkinson's disease,” Special Care in Dentistry, vol. 31, no. 5, pp. 178–181, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. M. Cicciù, G. Risitano, G. lo Giudice, and E. Bramanti, “Periodontal health and caries prevalence evaluation in patients affected by Parkinson's disease,” Parkinson's Disease, vol. 2012, Article ID 541908, 6 pages, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. J. Schwarz, E. Heimhilger, and A. Storch, “Increased periodontal pathology in Parkinson's disease,” Journal of Neurology, vol. 253, no. 5, pp. 608–611, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. E. R. Einarsdóttir, H. Gunnsteinsdóttir, M. H. Hallsdóttir et al., “Dental health of patients with Parkinson's disease in Iceland,” Special Care in Dentistry, vol. 29, no. 3, pp. 123–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Ferrari and R. Tarelli, “Parkinson's disease and systemic inflammation,” Parkinson's Disease, vol. 2011, Article ID 436813, 9 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. Cunningham, D. C. Wilcockson, S. Campion, K. Lunnon, and V. H. Perry, “Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration,” The Journal of Neuroscience, vol. 25, no. 40, pp. 9275–9284, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. K. L. Chou, M. Evatt, V. Hinson, and K. Kompoliti, “Sialorrhea in Parkinson's disease: a review,” Movement Disorders, vol. 22, no. 16, pp. 2306–2313, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. J. G. Kalf, B. R. Bloem, and M. Munneke, “Diurnal and nocturnal drooling in Parkinson's disease,” Journal of Neurology, vol. 259, no. 1, pp. 119–123, 2012. View at Publisher · View at Google Scholar · View at PubMed
  14. J. G. Kalf, B. J. M. de Swart, G. F. Borm, B. R. Bloem, and M. Munneke, “Prevalence and definition of drooling in Parkinson's disease: a systematic review,” Journal of Neurology, vol. 256, no. 9, pp. 1391–1396, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. A. Q. Rana, M. S. Yousuf, N. Awan, and A. Fattah, “Impact of progression of Parkinson's disease on drooling in various ethnic groups,” European Neurology, vol. 67, no. 5, pp. 312–314, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. L. L. Edwards, E. M. M. Quigley, and R. F. Pfeiffer, “Gastrointestinal dysfunction in Parkinson's disease: Frequency and pathophysiology,” Neurology, vol. 42, no. 4, pp. 726–732, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Srivanitchapoom, S. Pandey, and M. Hallett, “Drooling in Parkinson's disease: a review,” Parkinsonism and Related Disorders, vol. 20, no. 11, pp. 1109–1118, 2014. View at Publisher · View at Google Scholar · View at PubMed
  18. W. S. Crysdale, C. McCann, L. Roske, M. Joseph, D. Semenuk, and P. Chait, “Saliva control issues in the neurologically challenged: a 30 year experience in team management,” International Journal of Pediatric Otorhinolaryngology, vol. 70, no. 3, pp. 519–527, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. G. J. Limbrock, H. Fischer-Brandies, and C. Avalle, “Castillo-Morales’ orofacial therapy: treatment of 67 children with Down syndrome,” Developmental Medicine and Child Neurology, vol. 33, no. 4, pp. 296–303, 1991. View at Google Scholar · View at Scopus
  20. A. R. South, S. M. Somers, and M. S. Jog, “Gum chewing improves swallow frequency and latency in Parkinson patients: a preliminary study,” Neurology, vol. 74, no. 15, pp. 1198–1202, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. M. Borg and F. Hirst, “The role of radiation therapy in the management of sialorrhea,” International Journal of Radiation Oncology Biology Physics, vol. 41, no. 5, pp. 1113–1119, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Clifford and J. Finnerty, “The dental awareness and needs of a Parkinson's disease population.,” Gerodontology, vol. 12, no. 12, pp. 99–103, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. M. G. Cersósimo, O. R. Tumilasci, G. B. Raina et al., “Hyposialorrhea as an early manifestation of Parkinson disease,” Autonomic Neuroscience: Basic & Clinical, vol. 150, no. 1-2, pp. 150–151, 2009. View at Publisher · View at Google Scholar · View at PubMed
  24. C. Scully, “Drug effects on salivary glands: dry mouth,” Oral Diseases, vol. 9, no. 4, pp. 165–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Aframian, M. Helcer, D. Livni, S. D. M. Robinson, A. Markitziu, and C. Nadler, “Pilocarpine treatment in a mixed cohort of xerostomic patients,” Oral Diseases, vol. 13, no. 1, pp. 88–92, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. K. Ryo, A. Ito, R. Takatori et al., “Effects of coenzyme Q10 on salivary secretion,” Clinical Biochemistry, vol. 44, no. 8-9, pp. 669–674, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. A. D. Ha and J. Jankovic, “Pain in Parkinson's disease,” Movement Disorders, vol. 27, no. 4, pp. 485–491, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. M. Politis, K. Wu, S. Molloy, P. G. Bain, K. R. Chaudhuri, and P. Piccini, “Parkinson's disease symptoms: the patient's perspective,” Movement Disorders, vol. 25, no. 11, pp. 1646–1651, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. K. Samura, Y. Miyagi, T. Morioka et al., “Intractable facial pain in advanced Parkinson's disease alleviated by subthalamic nucleus stimulation,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 12, pp. 1410–1411, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. E. A. Coon and R. S. Laughlin, “Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause?” The Journal of Headache and Pain, vol. 13, no. 3, pp. 255–257, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. S. K. Jääskeläinen, “Pathophysiology of primary burning mouth syndrome,” Clinical Neurophysiology, vol. 123, no. 1, pp. 71–77, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. T. J. Clifford, M. J. Warsi, C. A. Burnett, and P. J. Lamey, “Burning mouth in Parkinson's disease sufferers,” Gerodontology, vol. 15, no. 2, pp. 73–78, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. P. López-Jornet, F. Camacho-Alonso, P. Andujar-Mateos, M. Sánchez-Siles, and F. Gómez-García, “Burning mouth syndrome : an update,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 15, no. 4, pp. e562–e568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. K. Jääskeläinen, J. O. Rinne, H. Forssell et al., “Role of the dopaminergic system in chronic pain—a fluorodopa-PET study,” Pain, vol. 90, no. 3, pp. 257–260, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Hagelberg, H. Forssell, J. O. Rinne et al., “Striatal dopamine D1 and D2 receptors in burning mouth syndrome,” Pain, vol. 101, no. 1-2, pp. 149–154, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Stuginski-Barbosa, G. G. R. Rodrigues, M. E. Bigal, and J. G. Speciali, “Burning mouth syndrome responsive to pramipexol,” Journal of Headache and Pain, vol. 9, no. 1, pp. 43–45, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. M. Bakke, S. L. Larsen, C. Lautrup, and M. Karlsborg, “Orofacial function and oral health in patients with Parkinson's disease,” European Journal of Oral Sciences, vol. 119, no. 1, pp. 27–32, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. Y. T. Kwak, I. W. Han, P. H. Lee, J. K. Yoon, and S. H. Suk, “Associated conditions and clinical significance of awake bruxism,” Geriatrics & Gerontology International, vol. 9, no. 4, pp. 382–390, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. K. M. Hathaway, “Bruxism: definition, measurement, and treatment,” in Orofacial Pain and Mandibular Disorder, J. R. Friction and R. B. Dubner, Eds., pp. 375–386, Raven Press, New York, NY, USA, 1995. View at Google Scholar
  40. E.-K. Tan, L.-L. Chan, and H.-M. Chang, “Severe bruxism following basal ganglia infarcts: insights into pathophysiology,” Journal of the Neurological Sciences, vol. 217, no. 2, pp. 229–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Srivastava, M. Ahuja, M. Srivastava, and A. Trivedi, “Bruxism as presenting feature of Parkinson's disease,” The Journal of the Association of Physicians of India, vol. 50, p. 457, 2002. View at Google Scholar · View at Scopus
  42. J. K. Sheffield and J. Jankovic, “Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease,” Expert Review of Neurotherapeutics, vol. 7, no. 6, pp. 637–647, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. G. M. Wali, “Asymmetrical awake bruxism associated with multiple system atrophy,” Movement Disorders, vol. 19, no. 3, pp. 352–355, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. K. R. Magee, “Bruxisma related to levodopa therapy,” The Journal of the American Medical Association, vol. 214, no. 1, p. 147, 1970. View at Google Scholar
  45. S. Abe, J.-F. Gagnon, J. Y. Montplaisir et al., “Sleep bruxism and oromandibular myoclonus in rapid eye movement sleep behavior disorder: a preliminary report,” Sleep Medicine, vol. 14, no. 10, pp. 1024–1030, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. F. Lobbezoo, J. van der Zaag, M. K. A. van Selms, H. L. Hamburger, and M. Naeije, “Principles for the management of bruxism,” Journal of Oral Rehabilitation, vol. 35, no. 7, pp. 509–523, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. K. Kashihara, A. Hanaoka, and T. Imamura, “Frequency and characteristics of taste impairment in patients with Parkinson's disease: results of a clinical interview,” Internal Medicine, vol. 50, no. 20, pp. 2311–2315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Sienkiewicz-Jarosz, A. Scinska, W. Kuran et al., “Taste responses in patients with Parkinson's disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 1, pp. 40–46, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. M. Shah, J. Deeb, M. Fernando et al., “Abnormality of taste and smell in Parkinson's disease,” Parkinsonism & Related Disorders, vol. 15, no. 3, pp. 232–237, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. H.-J. Kim, B. S. Jeon, J.-Y. Lee, Y.-J. Cho, K.-S. Hong, and J.-Y. Cho, “Taste function in patients with Parkinson disease,” Journal of Neurology, vol. 258, no. 6, pp. 1076–1079, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. J. G. Nutt, V. C. Anderson, J. H. Peacock, J. P. Hammerstad, and K. J. Burchiel, “DBS and diathermy interaction induces severe CNS damage,” Neurology, vol. 56, no. 10, pp. 1384–1386, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Roark, S. Whicher, and A. Abosch, “Reversible neurological symptoms caused by diathermy in a patient with deep brain stimulators: case report,” Neurosurgery, vol. 62, no. 1, p. E256, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus